These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26188133)

  • 21. Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration.
    Zhao M; Mantel I; Gelize E; Li X; Xie X; Arboleda A; Seminel M; Levy-Boukris R; Dernigoghossian M; Prunotto A; Andrieu-Soler C; Rivolta C; Canonica J; Naud MC; Lechner S; Farman N; Bravo-Osuna I; Herrero-Vanrell R; Jaisser F; Behar-Cohen F
    Nat Commun; 2019 Jan; 10(1):369. PubMed ID: 30664640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-angiogenic effects of non-peptide integrin alphavbeta3 specific antagonist on laser-induced choroidal neovascularization in mice.
    Honda S; Nagai T; Negi A
    Graefes Arch Clin Exp Ophthalmol; 2009 Apr; 247(4):515-22. PubMed ID: 19048271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
    Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q
    Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new kind of labyrinth-like capillary is responsible for leakage from human choroidal neovascular endothelium, as investigated by high-resolution electron microscopy.
    Schraermeyer U; Julien S; Biesemeier A; Bartz-Schmidt KU; Wolburg H
    Graefes Arch Clin Exp Ophthalmol; 2015 May; 253(5):681-9. PubMed ID: 25042819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amount of Mononuclear Phagocyte Infiltrate Does Not Predict Area of Experimental Choroidal Neovascularization (CNV).
    Will-Orrego A; Qiu Y; Fassbender ES; Shen S; Aranda J; Kotagiri N; Maker M; Liao SM; Jaffee BD; Poor SH
    J Ocul Pharmacol Ther; 2018 Sep; 34(7):489-499. PubMed ID: 30188257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration.
    Shin JY; Kwon KY; Byeon SH
    Acta Ophthalmol; 2015 Sep; 93(6):524-32. PubMed ID: 25581639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD.
    Wei X; Zhang T; Yao Y; Zeng S; Li M; Xiang H; Zhao C; Cao G; Li M; Wan R; Yang P; Yang J
    Exp Eye Res; 2018 Mar; 168():2-11. PubMed ID: 29284110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenic role of the Wnt signaling pathway activation in laser-induced choroidal neovascularization.
    Hu Y; Chen Y; Lin M; Lee K; Mott RA; Ma JX
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):141-54. PubMed ID: 23211829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration.
    Meredith EL; Mainolfi N; Poor S; Qiu Y; Miranda K; Powers J; Liu D; Ma F; Solovay C; Rao C; Johnson L; Ji N; Artman G; Hardegger L; Hanks S; Shen S; Woolfenden A; Fassbender E; Sivak JM; Zhang Y; Long D; Cepeda R; Liu F; Hosagrahara VP; Lee W; Tarsa P; Anderson K; Elliott J; Jaffee B
    J Med Chem; 2015 Dec; 58(23):9273-86. PubMed ID: 26568411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization.
    Lassota N; Prause JU; Scherfig E; Kiilgaard JF; la Cour M
    Acta Ophthalmol; 2010 May; 88(3):300-8. PubMed ID: 19416113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of Retinal Neovascularization by Anti-CCR3 Treatment in an Oxygen-Induced Retinopathy Model in Mice.
    Hirahara S; Nozaki M; Ohbayashi M; Hasegawa N; Ozone D; Ogura Y
    Ophthalmic Res; 2017; 58(1):56-66. PubMed ID: 28376500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression.
    Lavine JA; Farnoodian M; Wang S; Darjatmoko SR; Wright LS; Gamm DM; Ip MS; Sorenson CM; Sheibani N
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):299-308. PubMed ID: 28114591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An efficacy analysis of anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to multifocal choroiditis and comparison with wet age-related macular degeneration.
    Feng L; Hu JH; Chen J; Xie X
    J Zhejiang Univ Sci B; 2018 Apr.; 19(4):327-332. PubMed ID: 29616508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization.
    Tolentino MJ; Brucker AJ; Fosnot J; Ying GS; Wu IH; Malik G; Wan S; Reich SJ
    Retina; 2004 Feb; 24(1):132-8. PubMed ID: 15076954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHARACTERIZING THE EFFECT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ON TREATMENT-NAIVE CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Muakkassa NW; Chin AT; de Carlo T; Klein KA; Baumal CR; Witkin AJ; Duker JS; Waheed NK
    Retina; 2015 Nov; 35(11):2252-9. PubMed ID: 26457400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
    Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
    Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potent small molecule integrin antagonist THR-687 is a promising next-generation therapy for retinal vascular disorders.
    Hu TT; Vanhove M; Porcu M; Van Hove I; Van Bergen T; Jonckx B; Barbeaux P; Vermassen E; Feyen JHM
    Exp Eye Res; 2019 Mar; 180():43-52. PubMed ID: 30472075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Placenta Growth Factor Reduces Subretinal Mononuclear Phagocyte Accumulation in Choroidal Neovascularization.
    Crespo-Garcia S; Corkhill C; Roubeix C; Davids AM; Kociok N; Strauss O; Joussen AM; Reichhart N
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):4997-5006. PubMed ID: 28979997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretogranin III as a novel target for the therapy of choroidal neovascularization.
    LeBlanc ME; Wang W; Ji Y; Tian H; Liu D; Zhang X; Li W
    Exp Eye Res; 2019 Apr; 181():120-126. PubMed ID: 30633921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histamine H4 receptor as a new therapeutic target for choroidal neovascularization in age-related macular degeneration.
    Kaneko H; Ye F; Ijima R; Kachi S; Kato S; Nagaya M; Higuchi A; Terasaki H
    Br J Pharmacol; 2014 Aug; 171(15):3754-63. PubMed ID: 24787705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.